Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool

Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool

US Patent 9453199 · Granted Sep 27, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Non-signaling HIV fusion inhibitors and methods of use thereof2025
Chimeric antigen receptor T regulatory cells for the treatment of atherosclerosi2025
Targeted t cells with cytotoxicity toward immunosuppressive cells2025
Modified T cells and methods of their use2025
Compositions and methods for immune tolerance2025
Switch costimulatory receptors2025
Chimeric antigen receptor T cells targeting the tumor microenvironment2025
Compositions and methods for generating a persisting population of T cells usefu2025
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric a2025
Altering gene expression in cart cells and uses thereof2025
Use of trans-signaling approach in chimeric antigen receptors2025
Methods for improving the efficacy and expansion of immune cells2025